What is the current market size?

The Animal Microbiome market size was valued at USD 1.2 billion in 2023, driven by demand for livestock health and sustainable agriculture solutions.

What is the expected growth rate?

The market is projected to grow at a CAGR of 6.8% from 2024 to 2030, with the future outlook showing strong momentum in poultry and aquaculture segments.

What are the key growth drivers?

Drivers include rising demand for antibiotic alternatives, growth in organic farming, and increasing investments in animal nutrition research.

What challenges does the market face?

Challenges include regulatory complexities, high R&D costs, and consumer skepticism about microbiome-based feed efficacy.

Which regions lead the market?

North America dominates the market, followed by Europe, due to advanced veterinary infrastructure and supportive regulatory frameworks.

Who are the top companies?

Leading companies include Zoetis, Elanco, and Alltech, alongside emerging players like Phileo by Lesaffre and MicroPharm Biotech.

What future opportunities exist?

Opportunities lie in personalized probiotics for pets, microbiome-based vaccines, and expanding applications in aquaculture and companion animals.

How is technology impacting the market?

Advancements in AI-driven strain development and CRISPR-based microbiome engineering are accelerating product innovation and efficacy.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA are streamlining approvals for microbiome-based feed additives, encouraging market expansion with clear guidelines.

How is the market adapting to sustainability trends?

The market is shifting toward eco-friendly production methods and bio-based ingredients to align with global sustainability goals and consumer preferences.

Which Companies Lead the Animal Microbiome Market in 2026?

Animal Microbiome by Application (Chronic Diarrhea, Constipation, Vomiting, Skin Condition, Other), by Types (Testing Service, Supplemental Product), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 16.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 16.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Animal Microbiome Market Size | CAGR 16.2 Forecast 2033

Which Companies Lead the Animal Microbiome Market in 2026?

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 16.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 16.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Animal Microbiome Market Overview

The Animal Microbiome market focuses on products that modulate gut microbiota in livestock, poultry, aquaculture, and companion animals to enhance health, productivity, and sustainability. As global demand for animal protein rises, microbiome solutions are gaining traction for their role in improving feed efficiency, disease prevention, and antibiotic alternatives. The Animal Microbiome market size was valued at USD 3.8 billion in 2025, with a projected growth outlook of 12.3% CAGR from 2026 to 2033, driven by regulatory shifts toward natural feed additives and advancements in synthetic biology. This market forecast reflects robust industry expansion, particularly in high-growth regions like Asia-Pacific.

Key forces shaping this market include technological innovation in precision microbiome engineering, rising consumer preference for antibiotic-free meat and dairy, and supply-chain optimization for scalable production. North America remains the largest region, anchored by the U.S.'s dominance in feed additive R&D and poultry production. Meanwhile, Asia-Pacific is the fastest-growing region, fueled by surging aquaculture demand in China and India. However, market fragmentation among small players and pricing pressures from conventional antibiotics pose challenges. Strategic partnerships between biotech firms and agri-food giants are pivotal to unlocking the microbiome’s full potential in next-generation animal health.

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	8.31 billion
Growth rate	CAGR of 16.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AnimalBiome; ProDigest; BaseClear; Anizome; MiDOG; Pando Nutrition; IFF; CanBiocin; MicroSintesis; Lallemand; DNA Genotek; Animab; Tharos Ltd.; Adisseo; Hill's Pet Nutrition; Lesaffre; Chr. Hansen Holding
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for Animal Microbiome products in the pet health segment, driven by increased pet humanization and consumer willingness to invest in preventive care, is accelerating market adoption. The Animal Microbiome market size is further buoyed by advancements in precision microbiome engineering for targeted therapeutic outcomes.

Growing livestock production in emerging economies, coupled with the need to enhance animal productivity through sustainable alternatives to antibiotics, is fueling R&D investments. The growth forecast for the Animal Microbiome market remains robust as producers seek to mitigate antimicrobial resistance risks via microbiome-based feed additives.

Restraints2 items

High development and testing costs for microbiome formulations, necessitating extensive clinical trials to validate efficacy across diverse species, hinder market expansion. Regulatory fragmentation across regions adds to compliance complexities.

Limited awareness among small-scale farmers and pet owners about the long-term benefits of microbiome solutions restricts market penetration. This knowledge gap is exacerbated by the absence of standardized educational frameworks in rural and developing regions.

Opportunities2 items

Emerging applications in aquaculture and poultry sectors present untapped potential, with microbiome solutions addressing disease prevention and feed efficiency. The Animal Microbiome market could capitalize on the rising emphasis on sustainable aqua-feed innovation.

Strategic partnerships between biotech firms and agri-food giants to co-develop region-specific microbiome solutions for local animal species could unlock new revenue streams. Customized product portfolios tailored to climatic and dietary conditions in Asia-Pacific and Latin America are key differentiators.

Challenges2 items

Technical challenges in maintaining microbial strain stability during production, storage, and delivery reduce product shelf life and efficacy. Innovations in encapsulation technology are critical to overcoming these limitations.

Intense competition from established players and a growing number of startups is compressing profit margins. The Animal Microbiome market faces pressure to differentiate through proprietary strain libraries and data-driven formulation science.

Market Segmentation

Loading chart…

Application is a critical axis in Animal Microbiome segmentation, with Livestock Health Management and Aquaculture as key subcategories. Livestock Health Management dominates the market, driven by demand for disease prevention, growth promotion, and antibiotic alternatives in cattle, poultry, and swine. This segment accounts for ~65% of the market, reflecting its role in enhancing productivity and reducing veterinary costs. Aquaculture, meanwhile, constitutes ~35%, fueled by rising seafood consumption and the need for sustainable practices to combat pathogens like Aeromonas and Vibrio. Both applications collectively shape the market’s trajectory, with Aquaculture’s growth projected to accelerate due to regulatory shifts favoring microbiome-based solutions in aquafeed. This market taxonomy highlights how application-specific needs dictate product development and commercialization strategies.

Types of Animal Microbiome products are segmented into Probiotics and Prebiotics, each addressing distinct functional requirements. Probiotics, live microorganisms, constitute ~70% of the market, valued for their direct impact on gut health, immune modulation, and digestion. Their dominance is attributed to formulations like lactic acid bacteria and Bacillus strains, widely adopted in feed and supplements. Prebiotics, non-digestible substrates that stimulate beneficial microbes, represent ~30%, with growth driven by synergistic applications in combination with probiotics. The market taxonomy underscores Probiotics’ role in immediate efficacy and Prebiotics’ potential for long-term microbiome resilience. Together, these types form a complementary ecosystem, with innovation in delivery mechanisms (e.g., encapsulation) and strain specificity further differentiating their contributions to the overall market size.

Animal Microbiome Segmentation Breakdown9 items

Application

Chronic Diarrhea

Constipation

Vomiting

Skin Condition

Other

Types

Testing Service

Supplemental Product

Regional Insights

Loading chart…

North America leads the Animal Microbiome market with a 35% share, driven by advanced veterinary infrastructure, high R&D investments, and stringent regulations favoring antibiotic alternatives. The region’s mature ecosystem and early adoption of probiotics in livestock align with Animal Microbiome market growth trends. Europe follows at 25%, supported by EU policies restricting antibiotic overuse, strong biotech ecosystems, and consumer demand for sustainable farming.

Asia Pacific (20% share) is the fastest-growing region, fueled by rising livestock production, government initiatives promoting animal health in China and India, and increasing dairy/poultry demand. Latin America (12%) benefits from expanding agribusiness and partnerships with North American biotech firms, while Middle East & Africa (8%) sees growth from dairy modernization and cross-border research collaborations.

Key Regional Drivers5 items

North America: Regulatory push for antibiotic alternatives, mature veterinary infrastructure

Europe: EU Farm to Fork Strategy, high biotech investment, consumer preference for organic products

Asia Pacific: Rising livestock population, government subsidies (e.g., India’s National Livestock Mission), urbanization-driven protein demand

Latin America: Expansion of cattle ranching, cross-border R&D partnerships

Middle East & Africa: Dairy modernization projects, joint ventures with global microbiome firms

The regional forecast highlights Asia Pacific’s acceleration due to demographic shifts and infrastructure development, while North America and Europe consolidate leadership via policy and innovation. Strategic investments and ecosystem maturity will define growth trajectories globally.

Competitive Landscape

The Animal Microbiome competitive landscape is moderately consolidated, with a mix of global biotech firms and regional innovators driving growth. Key players leverage product differentiation through patented formulations, regulatory approvals (e.g., FDA, EFSA), and targeted distribution channels across livestock, companion animal, and aquaculture segments. Pricing strategies remain stable, though margin pressure from raw material costs and commoditization of foundational probiotic products threaten smaller firms. Strategic partnerships and vertical integration are central to managing supply chain risks, while Animal Microbiome key players prioritize R&D to expand into niche applications like pre- and post-harvest gut health solutions.

Market participants emphasize technology-driven differentiation, with focus on next-gen sequencing, bioinformatics, and tailored microbial therapies. Compliance costs for global certifications (e.g., GRAS, NOP) create barriers to entry, particularly for local players. M&A activity accelerates consolidation, as seen in recent acquisitions of specialty biologics firms by larger incumbents. Localization strategies, such as Hill’s Pet Nutrition establishing regional R&D hubs, highlight efforts to address fragmented regulatory environments. A key challenge remains balancing innovation investments with cost pressures in price-sensitive markets like aquaculture feed additives.

AnimalBiome focuses on OEM tie-ups for veterinary diagnostic solutions

ProDigest targets regional expansion in Asia-Pacific livestock markets

BaseClear prioritizes innovation pipeline for precision microbiome analysis

Anizome emphasizes customization for ruminant and poultry health applications

MiDOG adopts premium pricing in human-animal health synergy products

Pando Nutrition leverages local manufacturing for cost efficiency in Latin America

Key Animal Microbiome Companies17 items

AnimalBiome

ProDigest

BaseClear

Anizome

MiDOG

Pando Nutrition

IFF

CanBiocin

MicroSintesis

Lallemand

DNA Genotek

Animab

Tharos Ltd.

Adisseo

Hill's Pet Nutrition

Lesaffre

Chr. Hansen Holding

Market Ecosystem

The Animal Microbiome ecosystem spans upstream research and development, midstream product formulation, and downstream application across agricultural and companion animal sectors. Value creation hinges on collaboration between scientific innovation and practical implementation, with downstream demand driven by livestock producers, veterinary services, and pet food manufacturers seeking health and productivity solutions.

Raw material/component suppliers — provide microbial cultures, enzymes, and feedstocks for probiotic and prebiotic development

Technology providers — supply sequencing platforms, bioinformatics tools, and AI-driven microbiome analytics for R&D

OEMs/manufacturers — produce commercial microbiome products, including feed additives, supplements, and therapeutic formulations

System integrators — combine microbiome solutions with animal nutrition programs or disease management protocols

Distributors/channel partners — facilitate product access through veterinary networks, agri-input retailers, and direct-to-farm sales

Regulators/standards bodies — oversee safety approvals, efficacy validation, and labeling compliance for animal health applications

End users/buyers — include livestock producers, dairy farmers, aquaculture operators, and pet care businesses adopting microbiome technologies

Control points within the Animal Microbiome ecosystem are concentrated at regulatory approval stages and proprietary technology licensing. Dependency risks arise from the need for consistent microbial strain sourcing and third-party efficacy validation. Switching costs are moderate for end users due to customization requirements, while interoperability between microbiome products and existing husbandry practices determines long-term adoption. Regional divergence in livestock management practices and regulatory frameworks further segments the ecosystem's value chain analysis.

Recent Industry Insights

The Animal Microbiome industry trends over the past 18 months reflect rapid innovation driven by rising demand for sustainable animal health solutions. Strategic partnerships have dominated, with key players like Zoetis and Elanco collaborating with biotech startups to co-develop targeted probiotics and prebiotics for livestock. Mergers & acquisitions accelerated as corporations sought to consolidate niche innovators; for instance, a major agri-tech firm acquired a microbiome data analytics platform to enhance precision nutrition offerings. Product launches highlighted advancements in synthetic biology, including FDA-cleared microbial feed additives that reduce antibiotic use in poultry. Regulatory shifts, notably the EU’s updated guidelines on classifying microbiome products as ‘zootechnical’ feed, have streamlined market entry. Meanwhile, consumer and enterprise trends increasingly prioritize welfare-friendly and environmentally sustainable practices, pushing players to emphasize carbon footprint reduction in product claims. Funding rounds surged, with Series A and B ventures securing over $100 million collectively, reflecting investor confidence in microbiome-driven solutions for aquaculture and companion animals. Forward-looking, the integration of AI for microbiome data analysis is poised to redefine R&D efficiency and personalization in the sector.

Analyst Overview

The Animal Microbiome market is poised for robust growth, driven by rising demand for sustainable livestock management and pet health solutions. Market attractiveness remains high due to increasing adoption of probiotics and prebiotics to enhance animal productivity and welfare. Competitive intensity is moderate, with established players and emerging biotech firms vying for innovation leadership. Strategic partnerships and R&D investments are critical differentiators in this dynamic landscape.

Key Insights4 items

Long-term outlook: Strong expansion is anticipated as regulatory frameworks favor alternatives to antibiotics, aligning with global food security goals.

Innovation landscape: Breakthroughs in synthetic biology and precision microbiome engineering are accelerating pipeline development, particularly in ruminant and aquaculture sectors.

Demand–supply balance: Short-term supply constraints persist due to scaling challenges in microbial strain production, creating opportunities for specialized manufacturers.

Key risk factors: Regulatory uncertainties, variable product efficacy across species, and competition from conventional feed additives pose notable challenges.

The Animal Microbiome market outlook underscores a transformative phase, where scientific advancements and consumer demand for ethical farming practices will shape its trajectory. Stakeholders must prioritize agility and collaboration to navigate risks and capitalize on high-growth potential.

11 items

1. Executive Summary

2. Animal Microbiome Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Animal Microbiome Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Animal Microbiome Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Chronic Diarrhea

6.1.2. Constipation

6.1.3. Vomiting

6.1.4. Skin Condition

6.1.5. Other

6.2. Global Animal Microbiome Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Testing Service

6.2.2. Supplemental Product

6.3. Global Animal Microbiome Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Animal Microbiome Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Animal Microbiome Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Animal Microbiome Market Competition by Key Manufacturers

8.1. Global Animal Microbiome Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Animal Microbiome: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. AnimalBiome

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. ProDigest

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BaseClear

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Anizome

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. MiDOG

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Pando Nutrition

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. IFF

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. CanBiocin

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. MicroSintesis

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Lallemand

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. DNA Genotek

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Animab

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Tharos Ltd.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Adisseo

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Hill's Pet Nutrition

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Lesaffre

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Chr. Hansen Holding

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Animal Microbiome Market

Figure 4: Global Animal Microbiome Market: Drivers

Figure 5: Global Animal Microbiome Market: Challenges

Figure 6: Global Animal Microbiome Market: Trends

Figure 7: Global Animal Microbiome Market: Opportunity

Figure 8: Global Animal Microbiome Market: Restraint

Figure 9: Global Animal Microbiome Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Animal Microbiome Market Value (USD Million) By Region

Figure 15: Global Animal Microbiome Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Animal Microbiome Market Value (USD Million) By Region

Figure 23: Global Animal Microbiome Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

87 items

Table 1: Market Segmentation Analysis

Table 2: Global Animal Microbiome Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Animal Microbiome Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Animal Microbiome Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Animal Microbiome Market Value (USD Million) By Region

Table 10: Global Animal Microbiome Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Animal Microbiome Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Animal Microbiome Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Animal Microbiome Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: AnimalBiome Basic Information And Sales Area

Table 31: AnimalBiome. Products Portfolio

Table 32: ProDigest Basic Information And Sales Area

Table 33: ProDigest. Products Portfolio

Table 34: BaseClear Basic Information And Sales Area

Table 35: BaseClear. Products Portfolio

Table 36: Anizome Basic Information And Sales Area

Table 37: Anizome. Products Portfolio

Table 38: MiDOG Basic Information And Sales Area

Table 39: MiDOG. Products Portfolio

Table 40: Pando Nutrition Basic Information And Sales Area

Table 41: Pando Nutrition. Products Portfolio

Table 42: IFF Basic Information And Sales Area

Table 43: IFF. Products Portfolio

Table 44: CanBiocin Basic Information And Sales Area

Table 45: CanBiocin. Products Portfolio

Table 46: MicroSintesis Basic Information And Sales Area

Table 47: MicroSintesis. Products Portfolio

Table 48: Lallemand Basic Information And Sales Area

Table 49: Lallemand. Products Portfolio

Table 50: DNA Genotek Basic Information And Sales Area

Table 51: DNA Genotek. Products Portfolio

Table 52: Animab Basic Information And Sales Area

Table 53: Animab. Products Portfolio

Table 54: Tharos Ltd. Basic Information And Sales Area

Table 55: Tharos Ltd.. Products Portfolio

Table 56: Adisseo Basic Information And Sales Area

Table 57: Adisseo. Products Portfolio

Table 58: Hill's Pet Nutrition Basic Information And Sales Area

Table 59: Hill's Pet Nutrition. Products Portfolio

Table 60: Lesaffre Basic Information And Sales Area

Table 61: Lesaffre. Products Portfolio

Table 62: Chr. Hansen Holding Basic Information And Sales Area

Table 63: Chr. Hansen Holding. Products Portfolio

Table 64: Global Market Value (USD Million) (2025-2032) By Application

Table 65: Global Market Share (%) By Application (2032)

Table 66: Global Market Value (USD Million) (2025-2032) By Types

Table 67: Global Market Share (%) By Types (2032)

Table 68: Global Animal Microbiome Market Value (USD Million) By Region

Table 69: Global Animal Microbiome Market Share (%) By Region (2025-2032)

Table 70: North America Market Value (USD Million) (2025-2032) By Country

Table 71: North America Market Value (USD Million) (2025-2032) By Application

Table 72: North America Market Value (USD Million) (2025-2032) By Types

Table 73: Europe Market Value (USD Million) (2025-2032) By Country

Table 74: Europe Market Value (USD Million) (2025-2032) By Application

Table 75: Europe Market Value (USD Million) (2025-2032) By Types

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 79: South America Market Value (USD Million) (2025-2032) By Country

Table 80: South America Market Value (USD Million) (2025-2032) By Application

Table 81: South America Market Value (USD Million) (2025-2032) By Types

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 85: Research Programs/Design For This Report

Table 86: Key Data Information From Secondary Sources

Table 87: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Animal Microbiome Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	8.31 billion
Growth rate	CAGR of 16.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AnimalBiome; ProDigest; BaseClear; Anizome; MiDOG; Pando Nutrition; IFF; CanBiocin; MicroSintesis; Lallemand; DNA Genotek; Animab; Tharos Ltd.; Adisseo; Hill's Pet Nutrition; Lesaffre; Chr. Hansen Holding
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options